Literature DB >> 17196618

Expression of GATA-1 in a non-hematopoietic cell line induces beta-globin locus control region chromatin structure remodeling and an erythroid pattern of gene expression.

Michael E Layon1, Catherine J Ackley, Rachel J West, Christopher H Lowrey.   

Abstract

GATA-1 is a hematopoietic transcription factor expressed in erythroid, megakaryocytic, mast cell and eosinophil lineages. It is required for normal erythroid differentiation, the expression of erythroid-specific genes and for the establishment of an active chromatin structure throughout the beta-globin gene locus. GATA-1 is also necessary for the formation and function of the locus control region DNase I hypersensitive site (HS) core elements. To determine whether GATA-1 was sufficient to direct formation of the locus control region (LCR) and an erythroid pattern of gene expression, we expressed GATA-1 in the non-hematopoietic HeLa cell line that does not express other hematopoietic transcription factors but does express GATA-2, GATA-3, and GATA-6. We found that production of the GATA-1 protein resulted in the formation of LCR DNase I HSs 1-4 in their normal locations, and that histones became hyperacetylated within these regulatory elements. Transcription of several erythroid-specific genes was activated in HeLa cells expressing GATA-1, including those coding for alpha-globin, beta-globin, the erythropoietin receptor, the erythroid krüpple-like factor and p45 NF-E2. Despite increased expression of these genes at the mRNA level, their protein products were not detected. These results imply that GATA-1 is sufficient to direct chromatin structure reorganization within the beta-globin LCR and an erythroid pattern of gene expression in the absence of other hematopoietic transcription factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196618      PMCID: PMC1839823          DOI: 10.1016/j.jmb.2006.11.094

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  49 in total

1.  A PAR domain transcription factor is involved in the expression from a hematopoietic-specific promoter for the human LMO2 gene.

Authors:  Scott C Crable; Kathleen P Anderson
Journal:  Blood       Date:  2003-02-27       Impact factor: 22.113

Review 2.  Locus control regions.

Authors:  Qiliang Li; Kenneth R Peterson; Xiangdong Fang; George Stamatoyannopoulos
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

3.  Formation of a tissue-specific histone acetylation pattern by the hematopoietic transcription factor GATA-1.

Authors:  Danielle L Letting; Carrie Rakowski; Mitchell J Weiss; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

4.  A complex chromatin landscape revealed by patterns of nuclease sensitivity and histone modification within the mouse beta-globin locus.

Authors:  Michael Bulger; Dirk Schübeler; M A Bender; Joan Hamilton; Catherine M Farrell; Ross C Hardison; Mark Groudine
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

5.  Measurement of protein-DNA interactions in vivo by chromatin immunoprecipitation.

Authors:  Hogune Im; Jeffrey A Grass; Kirby D Johnson; Meghan E Boyer; Jing Wu; Emery H Bresnick
Journal:  Methods Mol Biol       Date:  2004

6.  Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation.

Authors:  Kathleen Freson; Gert Matthijs; Chantal Thys; Paul Mariën; Marc F Hoylaerts; Jos Vermylen; Chris Van Geet
Journal:  Hum Mol Genet       Date:  2002-01-15       Impact factor: 6.150

7.  Hematopoietic-specific activators establish an overlapping pattern of histone acetylation and methylation within a mammalian chromatin domain.

Authors:  Carol M Kiekhaefer; Jeffrey A Grass; Kirby D Johnson; Meghan E Boyer; Emery H Bresnick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-11       Impact factor: 11.205

8.  Evidence that DNase I hypersensitive site 5 of the human beta-globin locus control region functions as a chromosomal insulator in transgenic mice.

Authors:  Qiliang Li; Miaohua Zhang; Hemei Han; Alex Rohde; George Stamatoyannopoulos
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

9.  Induction of hemoglobin synthesis by xylosyladenine in murine erythroleukemia cells. Metabolism of xylosyladenine and effects on transmethylation.

Authors:  C Garrett; N M Kredich
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

10.  Fast chromatin immunoprecipitation assay.

Authors:  Joel D Nelson; Oleg Denisenko; Pavel Sova; Karol Bomsztyk
Journal:  Nucleic Acids Res       Date:  2006-01-05       Impact factor: 16.971

View more
  16 in total

1.  Hypoxia up-regulates expression of hemoglobin in alveolar epithelial cells.

Authors:  Christina L Grek; Danforth A Newton; Demetri D Spyropoulos; John E Baatz
Journal:  Am J Respir Cell Mol Biol       Date:  2010-05-27       Impact factor: 6.914

2.  GATA-1 modulates the chromatin structure and activity of the chicken alpha-globin 3' enhancer.

Authors:  Martín Escamilla-Del-Arenal; Félix Recillas-Targa
Journal:  Mol Cell Biol       Date:  2007-11-05       Impact factor: 4.272

3.  Developmental- and differentiation-specific patterns of human gamma- and beta-globin promoter DNA methylation.

Authors:  Rodwell Mabaera; Christine A Richardson; Kristin Johnson; Mei Hsu; Steven Fiering; Christopher H Lowrey
Journal:  Blood       Date:  2007-04-24       Impact factor: 22.113

Review 4.  GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.

Authors:  Te Ling; John D Crispino; Maria Zingariello; Fabrizio Martelli; Anna Rita Migliaccio
Journal:  Expert Rev Hematol       Date:  2018-02-19       Impact factor: 2.929

5.  Chromatin architecture and transcription factor binding regulate expression of erythrocyte membrane protein genes.

Authors:  Laurie A Steiner; Yelena Maksimova; Vincent Schulz; Clara Wong; Debasish Raha; Milind C Mahajan; Sherman M Weissman; Patrick G Gallagher
Journal:  Mol Cell Biol       Date:  2009-08-17       Impact factor: 4.272

6.  Dynamics of the epigenetic landscape during erythroid differentiation after GATA1 restoration.

Authors:  Weisheng Wu; Yong Cheng; Cheryl A Keller; Jason Ernst; Swathi Ashok Kumar; Tejaswini Mishra; Christapher Morrissey; Christine M Dorman; Kuan-Bei Chen; Daniela Drautz; Belinda Giardine; Yoichiro Shibata; Lingyun Song; Max Pimkin; Gregory E Crawford; Terrence S Furey; Manolis Kellis; Webb Miller; James Taylor; Stephan C Schuster; Yu Zhang; Francesca Chiaromonte; Gerd A Blobel; Mitchell J Weiss; Ross C Hardison
Journal:  Genome Res       Date:  2011-07-27       Impact factor: 9.043

7.  CDC6 expression is regulated by lineage-specific transcription factor GATA1.

Authors:  Bárbara Fernández-Morales; Leticia Pavón; Carmela Calés
Journal:  Cell Cycle       Date:  2012-08-08       Impact factor: 4.534

8.  Nkx2-5 represses Gata1 gene expression and modulates the cellular fate of cardiac progenitors during embryogenesis.

Authors:  Arianna Caprioli; Naoko Koyano-Nakagawa; Michelina Iacovino; Xiaozhong Shi; Anwarul Ferdous; Richard P Harvey; Eric N Olson; Michael Kyba; Daniel J Garry
Journal:  Circulation       Date:  2011-04-04       Impact factor: 29.690

9.  The distinctive roles of erythroid specific activator GATA-1 and NF-E2 in transcription of the human fetal γ-globin genes.

Authors:  Yea Woon Kim; Seoyeon Kim; Chul Geun Kim; AeRi Kim
Journal:  Nucleic Acids Res       Date:  2011-05-24       Impact factor: 16.971

10.  The effect of erythropoietin on normal and neoplastic cells.

Authors:  Steve Elliott; Angus M Sinclair
Journal:  Biologics       Date:  2012-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.